Business Description
Ovid Therapeutics is a US-based drug development company focused on creating new treatments for neurological conditions, particularly epilepsy and related brain disorders. Its two lead drugs are currently in early-stage clinical trials ? one targeting treatment-resistant epilepsy and another addressing psychosis linked to conditions such as Parkinson's disease and schizophrenia. The company works alongside several research and pharmaceutical partners, including AstraZeneca, Lundbeck, and Marinus Pharmaceuticals. Founded in 2014 and based in New York, Ovid continues to build its pipeline through both internal development and external collaborations.
